Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 51–76 of 76 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06615752	Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients	recruiting	Phase 1 / Phase 2	99	Charles Drew University of Medicine and ScienceOTHER	1	Apr 15, 2026	clinicaltrials
NCT06044857	PSMA PET Response Guided SabR in High Risk Pca	recruiting	Phase 1	20	University of Texas Southwestern Medical CenterOTHER	1	Apr 14, 2026	clinicaltrials